What were Max India Ltd(Merged)'s latest quarterly results?
Max India Ltd(Merged)'s latest quarterly results (Dec 2019) show
- PAT Growth YoY: +1323.3%
- Revenue Growth YoY: -2.9%
- Operating Margin: -34.0%
Max India Ltd(Merged) (Hospitals & Diagnostics) — fundamental analysis, earnings data, and key metrics. PE: 5.7. ROE: -3.7%. This stock is not currently in the Nifty 500 momentum outperformers list.
Based on publicly available financial data. This is educational research, not investment advice.
Max India Ltd(Merged)'s latest quarterly results (Dec 2019) show
Max India Ltd(Merged)'s current PE ratio is 5.7x.
Max India Ltd(Merged)'s price-to-book ratio is 1.6x.
Max India Ltd(Merged)'s fundamental strength based on key financial ratios
Max India Ltd(Merged) has a debt-to-equity ratio of N/A.
Max India Ltd(Merged)'s return ratios over recent years
Max India Ltd(Merged)'s operating cash flow is negative (FY2019).
Max India Ltd(Merged) currently does not pay a significant dividend (yield 0.00%).
Max India Ltd(Merged)'s shareholding pattern (Mar 2020)
Max India Ltd(Merged)'s promoter holding has remained stable recently.
Max India Ltd(Merged) is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Based on quantitative research signals, here is why Max India Ltd(Merged) may be worth studying
Max India Ltd(Merged) investment thesis summary:
Max India Ltd(Merged)'s forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.